{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:27:22Z","timestamp":1786782442816,"version":"build-2736575974"},"reference-count":37,"publisher":"Zhejiang University Press","issue":"8","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1631\/jzus.b2500477","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:31:58Z","timestamp":1783042318000},"page":"856-871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL-15 aggravates cardiac ischemic injury via impairing macrophage efferocytosis and driving inflammation","\u767d\u4ecb\u7d20-15\u901a\u8fc7\u635f\u5bb3\u5de8\u566c\u7ec6\u80de\u80de\u846c\u5e76\u9a71\u52a8\u708e\u75c7\u52a0\u91cd\u5fc3\u810f\u7f3a\u8840\u635f\u4f24"],"prefix":"10.1631","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5934-018X","authenticated-orcid":false,"given":"Lei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8849-7858","authenticated-orcid":false,"given":"Zhehui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiniu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayu","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6926-9516","authenticated-orcid":false,"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8421-2737","authenticated-orcid":false,"given":"Xiaojie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"635","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"477_CR1","doi-asserted-by":"publisher","first-page":"155258","DOI":"10.1016\/j.cyto.2020.155258","volume":"136","author":"H Allard-Chamard","year":"2020","unstructured":"Allard-Chamard H, Mishra HK, Nandi M, et al., 2020. Interleukin-15 in autoimmunity. Cytokine, 136:155258. https:\/\/doi.org\/10.1016\/j.cyto.2020.155258","journal-title":"Cytokine"},{"issue":"1","key":"477_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/FJC.0000000000000764","volume":"75","author":"K Ameri","year":"2020","unstructured":"Ameri K, Bayardorj D, Samurkashian R, et al., 2020. Administration of interleukin-15 peptide improves cardiac function in a mouse model of myocardial infarction. J Cardiovasc Pharmacol, 75(1):98\u2013102. https:\/\/doi.org\/10.1097\/FJC.0000000000000764","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"477_CR3","doi-asserted-by":"publisher","first-page":"H463","DOI":"10.1152\/ajpheart.00144.2003","volume":"285","author":"DQ Cai","year":"2003","unstructured":"Cai DQ, Xaymardan M, Holm JM, et al., 2003. Age-associated impairment in TNF-\u03b1 cardioprotection from myocardial infarction. Am J Physiol Heart Circ Physiol, 285(2):H463\u2013H469. https:\/\/doi.org\/10.1152\/ajpheart.00144.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"31","key":"477_CR4","doi-asserted-by":"publisher","first-page":"9692","DOI":"10.1073\/pnas.1420741112","volume":"112","author":"SL Colpitts","year":"2015","unstructured":"Colpitts SL, Puddington L, Lefran\u00e7ois L, 2015. IL-15 receptor \u03b1 signaling constrains the development of IL-17\u2013producing \u03b3\u03b4 T cells. Proc Natl Acad Sci USA, 112(31):9692\u20139697. https:\/\/doi.org\/10.1073\/pnas.1420741112","journal-title":"Proc Natl Acad Sci USA"},{"key":"477_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yjmcc.2020.06.006","volume":"145","author":"MJ Daseke II","year":"2020","unstructured":"Daseke MJ II, Tenkorang-Impraim MAA, Ma YG, et al., 2020. Exogenous IL-4 shuts off pro-inflammation in neutrophils while stimulating anti-inflammation in macrophages to induce neutrophil phagocytosis following myocardial infarction. J Mol Cell Cardiol, 145:112\u2013121. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.06.006","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"477_CR6","doi-asserted-by":"publisher","first-page":"e90960","DOI":"10.1371\/journal.pone.0090960","volume":"9","author":"E Dozio","year":"2014","unstructured":"Dozio E, Malavazos AE, Vianello E, et al., 2014. Interleukin-15 and soluble interleukin-15 receptor \u03b1 in coronary artery disease patients: association with epicardial fat and indices of adipose tissue distribution. PLoS ONE, 9(3):e90960. https:\/\/doi.org\/10.1371\/journal.pone.0090960","journal-title":"PLoS ONE"},{"issue":"11","key":"477_CR7","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1042\/CS20200402","volume":"134","author":"R Ghali","year":"2020","unstructured":"Ghali R, Habeichi NJ, Kaplan A, et al., 2020. IL-33 induces type-2-cytokine phenotype but exacerbates cardiac remodeling post-myocardial infarction with eosinophil recruitment, worsened systolic dysfunction, and ventricular wall rupture. Clin Sci, 134(11):1191\u20131218. https:\/\/doi.org\/10.1042\/CS20200402","journal-title":"Clin Sci"},{"issue":"1","key":"477_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cyto.2009.09.004","volume":"49","author":"C Gokkusu","year":"2010","unstructured":"Gokkusu C, Aydin M, Ozkok E, et al., 2010. Influences of genetic variants in interleukin-15 gene and serum interleukin-15 levels on coronary heart disease. Cytokine, 49(1):58\u201363. https:\/\/doi.org\/10.1016\/j.cyto.2009.09.004","journal-title":"Cytokine"},{"issue":"6","key":"477_CR9","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1111\/j.1471-4159.2008.05746.x","volume":"107","author":"D G\u00f3mez-Nicola","year":"2008","unstructured":"G\u00f3mez-Nicola D, Valle-Argos B, Suard\u00edaz M, et al., 2008. Role of IL-15 in spinal cord and sciatic nerve after chronic constriction injury: regulation of macrophage and T-cell infiltration. J Neurochem, 107(6):1741\u20131752. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05746.x","journal-title":"J Neurochem"},{"key":"477_CR10","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1038\/ncomms4147","volume":"5","author":"M Hamada","year":"2014","unstructured":"Hamada M, Nakamura M, Tran MTN, et al., 2014. MafB promotes atherosclerosis by inhibiting foam-cell apoptosis. Nat Commun, 5:3147. https:\/\/doi.org\/10.1038\/ncomms4147","journal-title":"Nat Commun"},{"issue":"5","key":"477_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/MCA.0000000000000877","volume":"31","author":"ZY Hao","year":"2020","unstructured":"Hao ZY, Ma J, Dai JJ, et al., 2020. A real-world analysis of cardiac rupture on incidence, risk factors and in-hospital outcomes in 4190 ST-elevation myocardial infarction patients from 2004 to 2015. Coron Artery Dis, 31(5):424\u2013429. https:\/\/doi.org\/10.1097\/MCA.0000000000000877","journal-title":"Coron Artery Dis"},{"issue":"11","key":"477_CR12","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1161\/01.CIR.99.11.1492","volume":"99","author":"MW Irwin","year":"1999","unstructured":"Irwin MW, Mak S, Mann DL, et al., 1999. Tissue expression and immunolocalization of tumor necrosis factor-\u03b1 in postinfarction dysfunctional myocardium. Circulation, 99(11):1492\u20131498. https:\/\/doi.org\/10.1161\/01.cir.99.11.1492","journal-title":"Circulation"},{"issue":"6","key":"477_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri.2017.28","volume":"17","author":"CV Jakubzick","year":"2017","unstructured":"Jakubzick CV, Randolph GJ, Henson PM, 2017. Monocyte differentiation and antigen-presenting functions. Nat Rev Immunol, 17(6):349\u2013362. https:\/\/doi.org\/10.1038\/nri.2017.28","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"477_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00395-017-0622-5","volume":"112","author":"M Jung","year":"2017","unstructured":"Jung M, Ma YG, Iyer RP, et al., 2017. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol, 112(3):33. https:\/\/doi.org\/10.1007\/s00395-017-0622-5","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"477_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijcard.2008.04.059","volume":"130","author":"JM Lambert","year":"2008","unstructured":"Lambert JM, Lopez EF, Lindsey ML, 2008. Macrophage roles following myocardial infarction. Int J Cardiol, 130(2):147\u2013158. https:\/\/doi.org\/10.1016\/j.ijcard.2008.04.059","journal-title":"Int J Cardiol"},{"key":"477_CR16","doi-asserted-by":"publisher","first-page":"106508","DOI":"10.1016\/j.intimp.2020.106508","volume":"84","author":"YF Li","year":"2020","unstructured":"Li YF, Feng LF, Li GR, et al., 2020. Resveratrol prevents ISO-induced myocardial remodeling associated with regulating polarization of macrophages through VEGF-B\/AMPK\/ NF-\u03baB pathway. Int Immunopharmacol, 84:106508. https:\/\/doi.org\/10.1016\/j.intimp.2020.106508","journal-title":"Int Immunopharmacol"},{"key":"477_CR17","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.2147\/JIR.S373962","volume":"15","author":"YQ Li","year":"2022","unstructured":"Li YQ, Sun XQ, Liu XN, et al., 2022. P2X7R-NEK7-NLRP3 inflammasome activation: a novel therapeutic pathway of Qishen granule in the treatment of acute myocardial ischemia. J Inflamm Res, 15:5309\u20135326. https:\/\/doi.org\/10.2147\/JIR.S373962","journal-title":"J Inflamm Res"},{"issue":"1","key":"477_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1631\/jzus.B2300097","volume":"25","author":"Y Luan","year":"2024","unstructured":"Luan Y, Yang Y, Luan Y, et al., 2024. Targeting ferroptosis and ferritinophagy: new targets for cardiovascular diseases. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 25(1):1\u201322. https:\/\/doi.org\/10.1631\/jzus.B2300097","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"},{"issue":"12","key":"477_CR19","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1182\/blood.V92.12.4828","volume":"92","author":"PP McDonald","year":"1998","unstructured":"McDonald PP, Russo MP, Ferrini S, et al., 1998. Interleukin-15 (IL-15) induces NF-\u03baB activation and IL-8 production in human neutrophils. Blood, 92(12):4828\u20134835. https:\/\/doi.org\/10.1182\/blood.V92.12.4828","journal-title":"Blood"},{"issue":"3","key":"477_CR20","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.4049\/jimmunol.173.3.1681","volume":"173","author":"E Mortier","year":"2004","unstructured":"Mortier E, Bernard J, Plet A, et al., 2004. Natural, proteolytic release of a soluble form of human IL-15 receptor \u03b1-chain that behaves as a specific, high affinity IL-15 antagonist. J Immunol, 173(3):1681\u20131688. https:\/\/doi.org\/10.4049\/jimmunol.173.3.1681","journal-title":"J Immunol"},{"issue":"5","key":"477_CR21","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.20071913","volume":"205","author":"E Mortier","year":"2008","unstructured":"Mortier E, Woo T, Advincula R, et al., 2008. IL-15R\u03b1 chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J Exp Med, 205(5):1213\u20131225. https:\/\/doi.org\/10.1084\/jem.20071913","journal-title":"J Exp Med"},{"issue":"12","key":"477_CR22","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s42255-023-00921-9","volume":"5","author":"D Ngai","year":"2023","unstructured":"Ngai D, Schilperoort M, Tabas I, 2023. Efferocytosis-induced lactate enables the proliferation of pro-resolving macrophages to mediate tissue repair. Nat Metab, 5(12):2206\u20132219. https:\/\/doi.org\/10.1038\/s42255-023-00921-9","journal-title":"Nat Metab"},{"key":"477_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2016.06.001","volume":"31","author":"M Patidar","year":"2016","unstructured":"Patidar M, Yadav N, Dalai SK, 2016. Interleukin 15: a key cytokine for immunotherapy. Cytokine Growth Factor Rev, 31:49\u201359. https:\/\/doi.org\/10.1016\/j.cytogfr.2016.06.001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"477_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.micinf.2011.10.006","volume":"14","author":"PY Perera","year":"2012","unstructured":"Perera PY, Lichy JH, Waldmann TA, et al., 2012. The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use. Microbes Infect, 14(3):247\u2013261. https:\/\/doi.org\/10.1016\/j.micinf.2011.10.006","journal-title":"Microbes Infect"},{"issue":"12","key":"477_CR25","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, et al., 2017. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med, 377(12):1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"},{"issue":"25","key":"477_CR26","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, et al., 2020. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol, 76(25):2982\u20133021. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.010","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"477_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000331720","volume":"28","author":"KP Stone","year":"2011","unstructured":"Stone KP, Kastin AJ, Pan WH, 2011. NF\u03baB is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia. Cell Physiol Biochem, 28(1):115\u2013124. https:\/\/doi.org\/10.1159\/000331720","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"477_CR28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.celrep.2016.09.008","volume":"17","author":"J van den Bossche","year":"2016","unstructured":"van den Bossche J, Baardman J, Otto NA, et al., 2016. Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep, 17(3):684\u2013696. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.008","journal-title":"Cell Rep"},{"key":"477_CR29","doi-asserted-by":"publisher","first-page":"110435","DOI":"10.1016\/j.intimp.2023.110435","volume":"121","author":"YC Wang","year":"2023","unstructured":"Wang YC, Zheng Y, Qi BC, et al., 2023. \u03b1-Lipoic acid alleviates myocardial injury and induces M2b macrophage polarization after myocardial infarction via HMGB1\/NF-\u03baB signaling pathway. Int Immunopharmacol, 121:110435. https:\/\/doi.org\/10.1016\/j.intimp.2023.110435","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"477_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jcmm.14741","volume":"24","author":"YZ Wei","year":"2020","unstructured":"Wei YZ, Lan Y, Zhong YC, et al., 2020. Interleukin-38 alleviates cardiac remodelling after myocardial infarction. J Cell Mol Med, 24(1):371\u2013384. https:\/\/doi.org\/10.1111\/jcmm.14741","journal-title":"J Cell Mol Med"},{"issue":"17","key":"477_CR31","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","volume":"67","author":"PC Westman","year":"2016","unstructured":"Westman PC, Lipinski MJ, Luger D, et al., 2016. Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol, 67(17):2050\u20132060. https:\/\/doi.org\/10.1016\/j.jacc.2016.01.073","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"477_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0002-9440(10)61712-9","volume":"159","author":"DM Wuttge","year":"2001","unstructured":"Wuttge DM, Eriksson P, Sirsj\u00f6 A, et al., 2001. Expression of interleukin-15 in mouse and human atherosclerotic lesions. Am J Pathol, 159(2):417\u2013423. https:\/\/doi.org\/10.1016\/S0002-9440(10)61712-9","journal-title":"Am J Pathol"},{"key":"477_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ijcard.2017.03.065","volume":"243","author":"WL Xuan","year":"2017","unstructured":"Xuan WL, Huang WX, Wang RJ, et al., 2017. Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction. Int J Cardiol, 243:367\u2013373. https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.065","journal-title":"Int J Cardiol"},{"key":"477_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","volume":"62","author":"XX Yan","year":"2013","unstructured":"Yan XX, Anzai A, Katsumata Y, et al., 2013. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol, 62:24\u201335. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.04.023","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"477_CR35","doi-asserted-by":"publisher","first-page":"e60227","DOI":"10.1371\/journal.pone.0060227","volume":"8","author":"YQ Zhang","year":"2013","unstructured":"Zhang YQ, Zhao JL, Lau WB, et al., 2013. Tumor necrosis factor-\u03b1 and lymphotoxin-\u03b1 mediate myocardial ischemic injury via TNF receptor 1, but are cardioprotective when activating TNF receptor 2. PLoS ONE, 8(5):e60227. https:\/\/doi.org\/10.1371\/journal.pone.0060227","journal-title":"PLoS ONE"},{"issue":"10","key":"477_CR36","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00109-014-1176-8","volume":"92","author":"SF Zhou","year":"2014","unstructured":"Zhou SF, Yuan J, Liao MY, et al., 2014. IL-17A promotes ventricular remodeling after myocardial infarction. J Mol Med, 92(10):1105\u20131116. https:\/\/doi.org\/10.1007\/s00109-014-1176-8","journal-title":"J Mol Med"},{"issue":"9","key":"477_CR37","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1631\/jzus.B2300691","volume":"25","author":"H Zou","year":"2024","unstructured":"Zou H, Zhang MY, Yang X, et al., 2024. Cynaroside regulates the AMPK\/SIRT3\/Nrf2 pathway to inhibit doxorubicin-induced cardiomyocyte pyroptosis. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 25(9):756\u2013772. https:\/\/doi.org\/10.1631\/jzus.B2300691","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2500477.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2500477","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2500477.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:20:12Z","timestamp":1786782012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2500477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2500477","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Lei GUO, Zhehui YIN, Ning ZHANG, Han CHEN, Zhuo WANG, Yuxue HUANG, Jiniu HUANG, Yayu YOU, Chenyun ZHANG, Qinyi BAO, Shuxin LEI, Jun JIANG, and Xiaojie XIE declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"This investigation was performed according to the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards, and written informed consent was obtained from all study participants prior to inclusion in the study with approval by the Ethics Committee of The Second Affiliated Hospital of Zhejiang University School of Medicine (No. 2021-0624). All animal procedures conformed to the guidelines from Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. The animal\u2019s study protocol was approved by the Ethics Committee of The Second Affiliated Hospital of Zhejiang University School of Medicine (No. AIRB-2021-1012). All institutional and national guidelines for the care and use of laboratory animals were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}